Cutia Therapeutics has announced changes in its management, effective 28 August 2025. Ms. Chan Sze Ting has resigned from her roles as company secretary, authorised representative, and process agent. Mr. Leung has been appointed as the new company secretary. Additionally, the company's principal place of business in Hong Kong has been relocated to 31/F, Tower Two, Times Square, 1 Matheson Street, Causeway Bay, Hong Kong.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cutia Therapeutics published the original content used to generate this news brief on August 28, 2025, and is solely responsible for the information contained therein.